Exploring New Frontiers in Food Allergy Treatments: Market Set for $14B Growth
USA News Group Commentary
Issued on behalf of BioVaxys Technology Corp.
VANCOUVER, BC, July 29, 2024 /PRNewswire/ — USA News Group – How and what we eat is always changing. But for more and more people, the options to eat are drastically being reduced, due to rising amounts of food allergies. According to Food Allergy Research & Education (FARE), food allergy prevalence among children has been surging, up by 50% between 1997 and 2011, and up again by another 50% between 2007 and 2021. Research analysts at Spherical Insights projects strong growth in the Global Allergy Treatment Market, growing at a CAGR of 9.27% to nearly US$14 billion by 2033. Now that food allergies affect more than 7% of American children, researchers are exploring different treatment approaches to tackle this serious and potentially lucrative issue, including BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF), Roche Holding AG (OTCQX: RHHBY), Novartis AG (NYSE: NVS), Neogen Corporation (NASDAQ: NEOG), and Thermo Fisher Scientific Inc. (NYSE: TMO).